Alectinib/Nivolumab/Paclitaxel

View at publisher
Cited by: 0
References: 1

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Lung Cancer Treatments and Mutations Pharmacovigilance and Adverse Drug Reactions

Publication details

Journal / source
Reactions Weekly
Volume
2093
Issue
1
Pages
19–19
Publication date
16 January 2026
Language
EN